Chimerix to Present at the 37th Annual J.P. Morgan Healthcare Conference
DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, […]
DURHAM, N.C., Jan. 04, 2019 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address life-threatening viral infections, […]
C4T’s targeted protein degradation platform provides a novel approach to neuroscience drug discovery and development, complementing Biogen’s broader research and […]
Biogen made a one-time upfront $74 million payment to Skyhawk for research services and an exclusive license to therapeutic candidates […]
Summit Therapeutics plc(“Summit Therapeutics” or the “Company”) Result of General Meeting Oxford, UK, and Cambridge, MA, US, 4 January 2019 […]
JOHNS CREEK, Ga., Jan. 04, 2019 (GLOBE NEWSWIRE) — Saia, Inc. (NASDAQ: SAIA), a leading transportation provider offering multi-regional less-than-truckload […]
EXTON, Pa., Jan. 04, 2019 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that the company will present […]
Acquisition strengthens U.S. platform in important Mid-Atlantic Region TORONTO and NORFOLK, Va., Jan. 04, 2019 (GLOBE NEWSWIRE) — Leading global […]
TORONTO and OTTAWA, Ontario, Jan. 04, 2019 (GLOBE NEWSWIRE) — Internet of Things Inc. (TSX VENTURE: ITT; OTC: INOTF; FRANKFURT: […]
GOLETA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]
GAITHERSBURG, Md., Jan. 04, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that its CEO Daniel J. […]